Recent studies have reported anti-apoptotic effects of SXR in liver and colon cancer cells [29,34] and proliferative effects in ovarian cancer cells in-vitro [70], whereas SXR activation, in-vivo, has been suggested to have pro-apoptotic effects in colon tissues [33]. The gene discussed is NR1I2; the disease is ovarian carcinoma.